biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a3xy-01a-11d-a23c-09
biospecimen_aliquot__bcr_aliquot_uuid	5978cf32-c471-4f15-879f-398acec6a866
biospecimen_aliquot__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0132260838
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2012-07-31
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a23c
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a3xy-01a-11d
biospecimen_analyte__bcr_analyte_uuid	0bf8a6a4-ab0a-4115-960d-811f95a06a05
biospecimen_analyte__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a3xy
biospecimen_diagnostic_slides__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	e57fc9bf-411e-4028-ac10-8bca5d0c8472
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a3xy
biospecimen_normal_control__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_normal_control__ncedna_dna_conc	0.139
biospecimen_normal_control__ncedna_dna_qm	spec(nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	143.9
biospecimen_portion__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_portion__bcr_portion_barcode	tcga-a2-a3xy-01a-11
biospecimen_portion__bcr_portion_uuid	fd36678e-8f2a-4047-b72f-7b919416e178
biospecimen_portion__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_portion__date_of_creation	2012-05-25
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a3xy-01a-11d
biospecimen_protocol__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_sample__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_sample__bcr_sample_uuid	da7fe5e0-6ae0-47f0-9b32-fb6b80c4be38
biospecimen_sample__days_to_collection	703
biospecimen_sample__initial_weight	950
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a3xy.ec1bb6e8-6897-4e70-80a6-5a4e4b9c4e1f.pdf
biospecimen_sample__pathology_report_uuid	ec1bb6e8-6897-4e70-80a6-5a4e4b9c4e1f
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
biospecimen_slide__bcr_sample_barcode	tcga-a2-a3xy-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a3xy-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	6437cd74-9c3d-481e-923e-00a8681ec078
biospecimen_slide__image_file_name	tcga-a2-a3xy-01a-01-tsa.6437cd74-9c3d-481e-923e-00a8681ec078.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	5
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	35
biospecimen_slide__percent_tumor_cells	60
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a3xy
biospecimen_tumor_sample__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
clinical_drug__bcr_drug_barcode	tcga-a2-a3xy-d34409
clinical_drug__bcr_drug_uuid	385416b0-05a4-45c0-a807-ddffe65c59ee
clinical_drug__bcr_patient_barcode	tcga-a2-a3xy
clinical_drug__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
clinical_drug__form_completion_date	2012-8-14
clinical_drug__pharmaceutical_therapy_drug_name	cyclophosphamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	170
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	170
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	yes
clinical_follow_up__bcr_followup_barcode	tcga-a2-a3xy-f43311
clinical_follow_up__bcr_followup_uuid	02379c43-db21-44a9-ae3c-0a268b0fab40
clinical_follow_up__bcr_patient_barcode	tcga-a2-a3xy
clinical_follow_up__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-5-16
clinical_follow_up__last_contact_days_to	1064
clinical_follow_up__new_tumor_event_dx_days_to	802
clinical_follow_up__new_tumor_event_dx_indicator	yes
clinical_follow_up__new_tumor_event_pharmaceutical_tx	yes
clinical_follow_up__new_tumor_event_radiation_tx	no
clinical_follow_up__new_tumor_event_site	lung
clinical_follow_up__new_tumor_event_surgery	no
clinical_follow_up__new_tumor_event_type	distant metastasis
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	with tumor
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	49
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-a2-a3xy
clinical_patient__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
clinical_patient__birth_days_to	-18059
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	negative
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2012-8-14
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.13
clinical_patient__her2_fish_status	negative
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	786
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	16
clinical_patient__lymph_nodes_examined_he_count	3
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a3xy
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	yes
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a3xy
clinical_radiation__bcr_patient_uuid	deba32e4-0e68-4711-941b-3b63bd965afb
clinical_radiation__bcr_radiation_barcode	tcga-a2-a3xy-r55837
clinical_radiation__bcr_radiation_uuid	0f6362e1-cae1-405e-9935-8d0eb86af3ef
clinical_radiation__form_completion_date	2014-1-16
clinical_radiation__radiation_adjuvant_fractions_total	6
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	1082
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	distant site
clinical_radiation__radiation_therapy_started_days_to	1074
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	1800
clinical_radiation__treatment_best_response	radiographic progressive disease
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A3XY-01A-11D-A23C-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A3XY-01A-11D-A23C-09.bed.meta
manually_curated__id	tcga-a2-a3xy-01a-11d-a23c-09
manually_curated__md5sum	648d8bd879910a05b2c17f162029b1cd
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	5978cf32-c471-4f15-879f-398acec6a866
manually_curated__tumor_tag	brca
